Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
17.40
-0.80 (-4.40%)
Jan 17, 2025, 4:00 PM EST - Market closed
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $31.02 million as of January 17, 2025. Its market cap has increased by 274.41% in one year.
Market Cap
31.02M
Enterprise Value
26.65M
1-Year Change
274.41%
Ranking
Category
Stock Price
$17.40
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $31.02M, a decrease of -46.68%. That is a compound annual growth rate of -27.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 31.02M | 20.08% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 341.33B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |